Developer docs
API playgroundTry for free, no card

Search company profiles

Vala Sciences

Full company profile

uuid0009czn

Namestring
Vala Sciences
Legal namestring
Vala Sciences
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Vala Sciences is a San Diego-based life-sciences tools company founded in 2004 that builds high-content kinetic screening technologies for drug discovery and preclinical safety assessment. The company's core hardware platform is the IC200-KIC® Kinetic Image Cytometer, which captures time-resolved cellular signals at single-cell resolution, paired with CyteSeer® software for image analysis and ValaSIM™ for low-phototoxicity 3D imaging of organoids and complex cell models. ValaDATE.AI™ serves as the company's AI-powered analytics layer, integrated with the proph𝔼CG™ assay to deliver cardiotoxicity prediction for drug safety screening. The company targets pharmaceutical and biotech researchers conducting drug discovery, disease modeling, and preclinical efficacy and safety programs, with use cases spanning cardiac safety screening, neurotoxicity screening, and neurodegenerative disease modeling.

Vala Sciences generates revenue through three streams: capital equipment sales (KIC instruments), software licensing (CyteSeer, ValaSIM), and contract research services spanning cardiac safety screening, neuroscience applications, and high-content analysis. The company also distributes antibodies and reagents as consumables. Go-to-market is enterprise field sales with direct engagement of researchers and pharmaceutical clients, supplemented by a direct website with e-commerce/contact-inquiry capability. The firm operates KIC® Global Research Centers of Excellence, indicating an international service footprint beyond its single San Diego headquarters.

The company is privately held with no disclosed funding rounds, parent company, or institutional investors, and is led by founder Jeffrey H. Price (President and CEO) alongside Chief Research Officer Patrick M. McDonough. Headcount is in the 11-50 range. No revenue, customer counts, partnership agreements, or certification/compliance credentials are disclosed in the available data, and the competitive moat rests on a vertically integrated branded platform (five registered trademarks), proprietary kinetic imaging datasets accumulated over two decades, and switching costs tied to validated assay workflows.

Short descriptiontext

Vala Sciences is a privately held San Diego life-sciences tools company that sells a high-content kinetic imaging platform (KIC®), analysis software (CyteSeer®, ValaSIM™), and AI-powered analytics (ValaDATE.AI™), plus contract research services, to pharmaceutical and biotech researchers for preclinical drug safety and efficacy screening.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
high-content screening, kinetic imaging cytometry, drug safety screening, cardiotoxicity prediction, contract research services
Industry2 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
High-Content Imaging Systems
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Instruments and Hardware Sales
TypeHardware Sales
Description

Sale of high-value scientific instruments including the IC200-KIC® Kinetic Image Cytometer system

vala-sciences.odoo.com
2Software Licenses
TypeSubscription Recurring
Description

Licensing of proprietary software including CyteSeer® and ValaSIM™ for image analysis and cellular analysis

vala-sciences.odoo.com
3Contract Research Services
TypeProfessional Services
Description

Providing specialized contract research services including cardiac safety screening, neuroscience applications, and high-content analysis for pharmaceutical and biotech clients

vala-sciences.odoo.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1KIC®
Description

Kinetic Image Cytometer IC200-KIC® sets the standard in high-content imaging, capturing subtle disease effects with single-cell precision.

vala-sciences.odoo.com
+4 more records
Core offering1 text field

Vala Sciences develops, manufactures, and sells high-content kinetic screening instruments and software, and provides contract research services for pharmaceutical and biotech researchers. The core product is the IC200-KIC Kinetic Image Cytometer paired with the CyteSeer, ValaSIM, and ValaDATE.AI software platforms, along with the proph𝔼CG assay for cardiotoxicity prediction. The company also offers outsourced cardiac safety, neuroscience, and high-content analysis services through its KIC Global Research Centers of Excellence.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Unmatched accuracy in cardiotoxicity prediction for drug safety screening
Product overview1 text field

Vala Sciences offers a unified portfolio of high-content kinetic screening technologies comprising instruments, software, and AI platforms, complemented by contract research services. The core hardware is the IC200-KIC Kinetic Image Cytometer, which captures kinetic (time-resolved) cellular signals at single-cell resolution. This instrument is paired with CyteSeer Software for advanced single-cell image analysis and ValaSIM for high-resolution low-phototoxicity 3D imaging of organoids. ValaDATE.AI serves as the AI-powered analytical platform that transforms the captured kinetic data into actionable drug discovery insights, while the proph𝔼CG assay enhances cardiotoxicity screening accuracy. Beyond product sales, Vala Sciences operates contract research services spanning cardiac safety screening (using ValaDATE.AI with proph𝔼CG), neuroscience applications for neurodegenerative disease modeling, and general high-content analysis — allowing clients to access the platform throughCRO services without purchasing instruments.

Product and service8 records
1IC200-KIC Kinetic Image Cytometer
CategoryInstruments
Description

Hardware instrument (Kinetic Image Cytometer, KIC) that sets the standard in high-content cellular imaging, capturing subtle disease effects with single-cell precision across kinetic (time-resolved) cellular assays, used by pharmaceutical and biotech researchers for drug discovery.

2CyteSeer Software
CategorySoftware
Description

Software platform that enables advanced single-cell analysis, revealing detailed cellular dynamics and subtle disease effects from high-content kinetic image data captured by the KIC instrument, used by researchers to characterize cellular responses.

3ValaSIM
CategorySoftware
Description

Software offering high-resolution 3D imaging with low phototoxicity, optimized for capturing complex structures such as organoids and 3D cell models in live-cell assays, used by researchers running 3D in vitro disease models.

4ValaDATE.AI
CategorySoftware
Description

AI-powered drug discovery platform that transforms kinetic cellular signals into precise, actionable insights from every drug-treated cell, integrated with the KIC instrument and proph𝔼CG assay for cardiotoxicity screening, used by pharmaceutical safety researchers.

5proph𝔼CG Assay
CategoryAssays and Reagents
Description

Cardiotoxicity assay used with ValaDATE.AI that delivers high-accuracy prediction of drug-induced cardiotoxicity in preclinical drug safety screening, sold to researchers running cardiac safety studies.

6Cardiac Safety Screening Service
CategoryContract Research Services
Description

Contract research service delivering cardiac safety assessment for pharmaceutical clients using ValaDATE.AI with proph𝔼CG to provide high-accuracy cardiotoxicity prediction in preclinical drug safety screening.

7Neuroscience Applications Service
CategoryContract Research Services
Description

Contract research service that applies high-content kinetic screening techniques to model neurodegenerative diseases and screen compounds for neurotoxicity, provided to pharmaceutical and academic neuroscience researchers.

8High-Content Analysis Service
CategoryContract Research Services
Description

Contract research service that delivers advanced high-content analysis to assess drug efficacy and safety, providing precise single-cell insights for preclinical research clients.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Market leader in high-content screening (ImageXpress) serving drug discovery researchers. Directly competes with Vala's KIC instrument and CyteSeer software in cellular imaging and analysis workflows.

TypeBroad incumbent
Description

Operates Cellomics high-content screening and a broad life sciences instruments and CRO portfolio. Comparable in target customer (pharma/biotech researchers) and overlapping product categories in imaging and cell analysis.

TypeBroad incumbent
Description

Provides high-content screening instruments (Operetta), imaging software, and reagents, plus contract research services. Overlaps with Vala across instruments, software, and preclinical drug safety offerings.

TypeDirect peer
Description

Through the Essen BioScience acquisition, Sartorius offers the Incucyte live-cell imaging platform. Closely comparable to Vala's kinetic, live-cell imaging approach for pharma researchers.

TypeDirect peer
Description

Sells the CellVoyager high-content screening system for live-cell imaging. Competes head-to-head with KIC in single-cell kinetic imaging workflows for drug discovery.

TypeDirect peer
Description

Provides cardiotoxicity screening instrumentation (e.g., CardioExcyte 96) for hiPSC-derived cardiomyocytes. Closely comparable to Vala's cardiac safety screening focus and contract research offering.

TypeEmerging player
Description

Offers functional cell analysis platforms (Maestro) for cardiomyocyte and neural assays. Comparable in hiPSC-derived cardiac and neuro screening use cases, though with MEA-based rather than imaging-based readouts.

TypeEmerging player
Description

Provides compact live-cell imaging devices with cloud-based AI analysis. Adjacent in cellular kinetic imaging and AI analytics, though positioned at smaller scale than Vala's enterprise KIC platform.

TypeBroad incumbent
Description

Bioprinting and life science tools company with expanding presence in cell biology, organoids, and lab automation. Adjacent competitor in 3D cell models and organoid workflows overlapping with ValaSIM.

TypeBroad incumbent
Description

Large preclinical CRO offering cardiac safety and neuroscience assessment services. Comparable to Vala's contract research arm, though at much greater scale and broader scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vala Sciences

High-Content Imaging Systemsvalasciences.com

Vala Sciences is a privately held San Diego life-sciences tools company that sells a high-content kinetic imaging platform (KIC®), analysis software (CyteSeer®, ValaSIM™), and AI-powered analytics (ValaDATE.AI™), plus contract research services, to pharmaceutical and biotech researchers for preclinical drug safety and efficacy screening.

What Vala Sciences does

Vala Sciences is a San Diego-based life-sciences tools company founded in 2004 that builds high-content kinetic screening technologies for drug discovery and preclinical safety assessment. The company's core hardware platform is the IC200-KIC® Kinetic Image Cytometer, which captures time-resolved cellular signals at single-cell resolution, paired with CyteSeer® software for image analysis and ValaSIM™ for low-phototoxicity 3D imaging of organoids and complex cell models. ValaDATE.AI™ serves as the company's AI-powered analytics layer, integrated with the proph𝔼CG™ assay to deliver cardiotoxicity prediction for drug safety screening. The company targets pharmaceutical and biotech researchers conducting drug discovery, disease modeling, and preclinical efficacy and safety programs, with use cases spanning cardiac safety screening, neurotoxicity screening, and neurodegenerative disease modeling.

Vala Sciences generates revenue through three streams: capital equipment sales (KIC instruments), software licensing (CyteSeer, ValaSIM), and contract research services spanning cardiac safety screening, neuroscience applications, and high-content analysis. The company also distributes antibodies and reagents as consumables. Go-to-market is enterprise field sales with direct engagement of researchers and pharmaceutical clients, supplemented by a direct website with e-commerce/contact-inquiry capability. The firm operates KIC® Global Research Centers of Excellence, indicating an international service footprint beyond its single San Diego headquarters.

The company is privately held with no disclosed funding rounds, parent company, or institutional investors, and is led by founder Jeffrey H. Price (President and CEO) alongside Chief Research Officer Patrick M. McDonough. Headcount is in the 11-50 range. No revenue, customer counts, partnership agreements, or certification/compliance credentials are disclosed in the available data, and the competitive moat rests on a vertically integrated branded platform (five registered trademarks), proprietary kinetic imaging datasets accumulated over two decades, and switching costs tied to validated assay workflows.

Vala Sciences firmographics

Firmographics
Name
Vala Sciences
Legal name
Vala Sciences
Website
https://valasciences.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Vala Sciences is a privately held San Diego life-sciences tools company that sells a high-content kinetic imaging platform (KIC®), analysis software (CyteSeer®, ValaSIM™), and AI-powered analytics (ValaDATE.AI™), plus contract research services, to pharmaceutical and biotech researchers for preclinical drug safety and efficacy screening.
Ownership category
akta.pro rank

Vala Sciences industry classification

Industry
Product category
High-Content Imaging Systems
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Other Scientific and Technical Consulting Services (54169)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • High-content screening
  • Kinetic imaging cytometry
  • Drug safety screening
  • Cardiotoxicity prediction
  • Contract research services

Where Vala Sciences is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vala Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Instruments and Hardware Sales: Sale of high-value scientific instruments including the IC200-KIC® Kinetic Image Cytometer system
  2. Software Licenses: Licensing of proprietary software including CyteSeer® and ValaSIM™ for image analysis and cellular analysis
  3. Contract Research Services: Providing specialized contract research services including cardiac safety screening, neuroscience applications, and high-content analysis for pharmaceutical and biotech clients

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Vala Sciences product offering

Product offering

Core offering

Vala Sciences develops, manufactures, and sells high-content kinetic screening instruments and software, and provides contract research services for pharmaceutical and biotech researchers. The core product is the IC200-KIC Kinetic Image Cytometer paired with the CyteSeer, ValaSIM, and ValaDATE.AI software platforms, along with the proph𝔼CG assay for cardiotoxicity prediction. The company also offers outsourced cardiac safety, neuroscience, and high-content analysis services through its KIC Global Research Centers of Excellence.

Product overview

Vala Sciences offers a unified portfolio of high-content kinetic screening technologies comprising instruments, software, and AI platforms, complemented by contract research services. The core hardware is the IC200-KIC Kinetic Image Cytometer, which captures kinetic (time-resolved) cellular signals at single-cell resolution. This instrument is paired with CyteSeer Software for advanced single-cell image analysis and ValaSIM for high-resolution low-phototoxicity 3D imaging of organoids. ValaDATE.AI serves as the AI-powered analytical platform that transforms the captured kinetic data into actionable drug discovery insights, while the proph𝔼CG assay enhances cardiotoxicity screening accuracy. Beyond product sales, Vala Sciences operates contract research services spanning cardiac safety screening (using ValaDATE.AI with proph𝔼CG), neuroscience applications for neurodegenerative disease modeling, and general high-content analysis — allowing clients to access the platform throughCRO services without purchasing instruments.

Differentiator

Problem solved

Functional benefit

Brands

  • KIC®: Kinetic Image Cytometer IC200-KIC® sets the standard in high-content imaging, capturing subtle disease effects with single-cell precision.
  • CyteSeer®
  • ValaSIM™
  • ValaDATE.AI™
  • proph𝔼CG™

Products and services

  • IC200-KIC Kinetic Image Cytometer Hardware instrument (Kinetic Image Cytometer, KIC) that sets the standard in high-content cellular imaging, capturing subtle disease effects with single-cell precision across kinetic (time-resolved) cellular assays, used by pharmaceutical and biotech researchers for drug discovery.
  • CyteSeer Software Software platform that enables advanced single-cell analysis, revealing detailed cellular dynamics and subtle disease effects from high-content kinetic image data captured by the KIC instrument, used by researchers to characterize cellular responses.
  • ValaSIM Software offering high-resolution 3D imaging with low phototoxicity, optimized for capturing complex structures such as organoids and 3D cell models in live-cell assays, used by researchers running 3D in vitro disease models.
  • ValaDATE.AI AI-powered drug discovery platform that transforms kinetic cellular signals into precise, actionable insights from every drug-treated cell, integrated with the KIC instrument and proph𝔼CG assay for cardiotoxicity screening, used by pharmaceutical safety researchers.
  • proph𝔼CG Assay Cardiotoxicity assay used with ValaDATE.AI that delivers high-accuracy prediction of drug-induced cardiotoxicity in preclinical drug safety screening, sold to researchers running cardiac safety studies.
  • Cardiac Safety Screening Service Contract research service delivering cardiac safety assessment for pharmaceutical clients using ValaDATE.AI with proph𝔼CG to provide high-accuracy cardiotoxicity prediction in preclinical drug safety screening.
  • Neuroscience Applications Service Contract research service that applies high-content kinetic screening techniques to model neurodegenerative diseases and screen compounds for neurotoxicity, provided to pharmaceutical and academic neuroscience researchers.
  • High-Content Analysis Service Contract research service that delivers advanced high-content analysis to assess drug efficacy and safety, providing precise single-cell insights for preclinical research clients.

Quantifiable outcome

  • Unmatched accuracy in cardiotoxicity prediction for drug safety screening

Companies that use Vala Sciences

Customer profile

Segments2 records

Ideal customer profiles1 record

Vala Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Vala Sciences partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Vala Sciences competitors and assessment

Company assessment

Direct peers

  • Molecular Devices (Danaher): Market leader in high-content screening (ImageXpress) serving drug discovery researchers. Directly competes with Vala's KIC instrument and CyteSeer software in cellular imaging and analysis workflows.
  • Sartorius (Essen BioScience): Through the Essen BioScience acquisition, Sartorius offers the Incucyte live-cell imaging platform. Closely comparable to Vala's kinetic, live-cell imaging approach for pharma researchers.
  • Yokogawa Electric (CellVoyager): Sells the CellVoyager high-content screening system for live-cell imaging. Competes head-to-head with KIC in single-cell kinetic imaging workflows for drug discovery.
  • Nanion Technologies: Provides cardiotoxicity screening instrumentation (e.g., CardioExcyte 96) for hiPSC-derived cardiomyocytes. Closely comparable to Vala's cardiac safety screening focus and contract research offering.

Broad incumbents

  • Thermo Fisher Scientific: Operates Cellomics high-content screening and a broad life sciences instruments and CRO portfolio. Comparable in target customer (pharma/biotech researchers) and overlapping product categories in imaging and cell analysis.
  • PerkinElmer (Revvity): Provides high-content screening instruments (Operetta), imaging software, and reagents, plus contract research services. Overlaps with Vala across instruments, software, and preclinical drug safety offerings.
  • BICO (CELLINK): Bioprinting and life science tools company with expanding presence in cell biology, organoids, and lab automation. Adjacent competitor in 3D cell models and organoid workflows overlapping with ValaSIM.
  • Charles River Laboratories: Large preclinical CRO offering cardiac safety and neuroscience assessment services. Comparable to Vala's contract research arm, though at much greater scale and broader scope.

Emerging players

  • Axion Biosystems: Offers functional cell analysis platforms (Maestro) for cardiomyocyte and neural assays. Comparable in hiPSC-derived cardiac and neuro screening use cases, though with MEA-based rather than imaging-based readouts.
  • CytoSMART Technologies: Provides compact live-cell imaging devices with cloud-based AI analysis. Adjacent in cellular kinetic imaging and AI analytics, though positioned at smaller scale than Vala's enterprise KIC platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Vala Sciences social profiles

Digital presence

Vala Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vala Sciences leadership team

Management profile

Number of profiles

Profiles2 records

Vala Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vala Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vala Sciences

What does Vala Sciences do?

Vala Sciences develops, manufactures, and sells high-content kinetic screening instruments and software, and provides contract research services for pharmaceutical and biotech researchers. The core product is the IC200-KIC Kinetic Image Cytometer paired with the CyteSeer, ValaSIM, and ValaDATE.AI software platforms, along with the proph𝔼CG assay for cardiotoxicity prediction. The company also offers outsourced cardiac safety, neuroscience, and high-content analysis services through its KIC Global Research Centers of Excellence.

Is Vala Sciences a public or private company?

Vala Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vala Sciences founded?

Vala Sciences was founded in 2004. It employs 11 to 50 people.

Where is Vala Sciences based?

Vala Sciences is headquartered in San Diego, United States, in the North America region.

How does Vala Sciences make money?

Three revenue lines are on record. Instruments and Hardware Sales are the primary driver. The others are software Licenses and contract Research Services.

Who are Vala Sciences's main competitors?

Direct peers on record are Molecular Devices (Danaher), Sartorius (Essen BioScience), Yokogawa Electric (CellVoyager) and Nanion Technologies. Broad incumbents are Thermo Fisher Scientific, PerkinElmer (Revvity), BICO (CELLINK) and Charles River Laboratories. Emerging players are Axion Biosystems and CytoSMART Technologies.

Does Vala Sciences have an API?

No public API is recorded for Vala Sciences.

What industry is Vala Sciences in?

Vala Sciences's product category is High-Content Imaging Systems. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales